Breaking News Instant updates and real-time market news.

FNSR

Finisar

$27.25

-0.11 (-0.40%)

04:55
03/21/17
03/21
04:55
03/21/17
04:55

Finisar management to meet with Craig-Hallum

Meeting to be held in Los Angeles on March 21 hosted by Craig-Hallum.

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

FNSR Finisar
$27.25

-0.11 (-0.40%)

03/13/17
03/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Needham analyst N. Quinn Bolton upgraded Marvell (MRVL) to Buy from Hold, with a $21 price target, following the company's inaugural analyst day, in which management laid out its strategy to grow revenue, further streamline operations and increase capital returns to shareholders. 2. Raymond James analyst Simon Leopold upgraded Finisar (FNSR) to Strong Buy from Outperform citing the 23% selloff in shares on Friday. The analyst believes the company's execution issues are "either misunderstood or exaggerated." He sees upside to estimates and has a $40 price target for the shares. 3. Morgan Stanley analyst Rajeev Lalwani upgraded Rockwell Collins (COL) to Overweight from Equal Weight and raised his price target for the shares to $121 from $94. 4. Citi analyst Michael Rollins upgraded Equinix (EQIX) to Buy from Neutral citing prospects for faster growth from the company's European portfolio as well as acquisitions. The analyst raised his price target for the shares to $435. 5. Goldman Sachs analyst Terence Flynn upgraded Blueprint Medicines (BPMC) to Buy from Neutral citing pipeline momentum following last year's data readouts. The analyst expects a "steady flow" of readouts at conferences this year from the extension phases of trials and clarity on potential registration paths. He upped his price target for the shares to $52 from $35. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/15/17
JEFF
03/15/17
UPGRADE
Target $34
JEFF
Buy
Finisar upgraded to Buy from Hold at Jefferies
Jefferies analyst James Kisner upgraded Finisar to Buy saying the current valuation discounts no recovery in China and no resolution of recent technical issues. The analyst views the company's issues as temporary and upped his price target for the shares to $34 from $32.
03/15/17
03/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Hold from Underperform at Jefferies with analyst John Janedis saying he believes Netflix's international growth opportunity is larger than he had expected. The company's original content is performing well, mobile consumption is growing and competition appears limited, Janedis tells investors in a research note. 2. CSX (CSX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Amec Foster Wheeler (AMFW) was upgraded to Neutral from Underperform at Exane BNP Paribas and to Outperform from Market Perform at Raymond James. 4. Harley-Davidson (HOG) upgraded to Neutral from Underperform at Longbow. 5. Finisar (FNSR) upgraded to Buy from Hold at Jefferies with analyst James Kisner saying the current valuation discounts no recovery in China and no resolution of recent technical issues. The analyst views the company's issues as temporary and upped his price target for the shares to $34 from $32. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/16/17
BNCH
03/16/17
NO CHANGE
Target $40
BNCH
Buy
II-VI selloff a buying opportunity, says Benchmark
Benchmark analyst Mark Miller noted that a recent selloff in several optical telecom equipment stocks - including II-VI (IIVI), Lumentum (LITE), and Oclaro (OCLR) - has followed the disappointing earnings and guidance issued by Finisar (FNSR). Additionally weighing on II-VI was technical selling after its stock fell below its 50-day moving average, Miller tells investors. He said he views the selloff in II-VI as a buying opportunity and keeps a Buy rating and $40 price target on the shares.

TODAY'S FREE FLY STORIES

FFIV

F5 Networks

$128.20

0.18 (0.14%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
F5 Networks sees Q4 non-GAAP EPS $2.20-$2.23, consensus $2.24 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 05

    Sep

MPWR

Monolithic Power

$106.79

1.86 (1.77%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Monolithic Power reports Q2 EPS 68c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

  • 10

    Aug

  • 15

    Aug

O

Realty Income

$57.92

0.49 (0.85%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Realty Income reports Q2 EPS 30c, consensus 32c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FMNB

Farmers National Banc

$14.35

-0.4 (-2.71%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Farmers National Banc reports Q2 EPS 21c, consensus 22c »

Total loans were $1.51…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$43.86

-0.13 (-0.30%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Hot Stocks
Mercury Systems receives $5.5M order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 07

    Aug

ESND

Essendant

$13.41

-0.42 (-3.04%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Essendant sees FY17 sales decline of 6%-9%, consensus $5.22B »

Management said, "In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Options
Preliminary option volume of 17.4M today »

Preliminary option volume…

NTRI

Nutrisystem

$62.95

1.3 (2.11%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Hot Stocks
Breaking Hot Stocks news story on Nutrisystem »

Nutrisystem trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

UDR

UDR, Inc.

$39.19

0.51 (1.32%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Earnings
UDR, Inc. reports Q2 AFFO 43c vs. 41c last year »

UDR reports Q2 Funds from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FFIV

F5 Networks

$128.20

0.18 (0.14%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Earnings
F5 Networks reports Q3 non-GAAP EPS $2.03, consensus $2.03 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 05

    Sep

FORR

Forrester

$41.60

0.15 (0.36%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Earnings
Forrester sees FY17 pro forma EPS $1.13-$1.20, consensus $1.17 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

BAC

Bank of America

$24.21

-0.27 (-1.10%)

, PYPL

PayPal

$58.79

0.53 (0.91%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Hot Stocks
PayPal, BofA partner to enable in-store payments and account linking »

Bank of America (BAC) and…

BAC

Bank of America

$24.21

-0.27 (-1.10%)

PYPL

PayPal

$58.79

0.53 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 09

    Aug

  • 10

    Aug

AXTI

AXT, Inc.

$7.60

0.25 (3.40%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
AXT, Inc. reports Q2 EPS 5c, consensus 5c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 03

    Aug

  • 10

    Aug

  • 19

    Sep

UDR

UDR, Inc.

$39.19

0.51 (1.32%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
UDR, Inc. reports Q2 EPS 3c, consensus 6c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ESND

Essendant

$13.41

-0.42 (-3.04%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
Essendant reports Q2 adjusted EPS 28c, consensus 37c »

Reports Q2 revenue $1.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

KS

KapStone

$22.52

-0.17 (-0.75%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
KapStone reports Q2 adjusted EPS 27c, consensus 27c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FORR

Forrester

$41.60

0.15 (0.36%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
Forrester sees Q3 pro forma EPS 21c-25c, consensus 26c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

AHL

Aspen Insurance

$51.00

-0.75 (-1.45%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Aspen Insurance reports Q2 ops EPS 47c, consensus $1.00 »

Chris O'Kane, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

OKE

Oneok

$55.59

-0.19 (-0.34%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Hot Stocks
Oneok raises quarterly dividend 21% to 74.5c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

MB

Mindbody

$26.10

-0.05 (-0.19%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Breaking Earnings news story on Mindbody »

Mindbody sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

TYL

Tyler Technologies

$181.33

0.32 (0.18%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Tyler Technologies sees FY17 EPS $3.83-$3.91, consensus $3.88 »

Sees FY17 GAAP revenues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

  • 05

    Sep

INVA

Innoviva

$13.19

0.08 (0.61%)

16:27
07/26/17
07/26
16:27
07/26/17
16:27
Earnings
Innoviva reports Q2 adjusted EPS 35c, consensus 27c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

KEX

Kirby

$65.20

-0.2 (-0.31%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Earnings
Kirby narrows 2017 EPS outlook to $1.80-$2.10, consensus $2.07 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

FORR

Forrester

$41.60

0.15 (0.36%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Earnings
Forrester reports Q2 pro forma EPS 42c, consensus 30c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CAPL

CrossAmerica

$28.05

-0.62 (-2.16%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Hot Stocks
CrossAmerica increases quarterly distribution 0.8% »

CrossAmerica Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.